CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $143,942 | +25.1% | 40,320 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $115,103 | +27.9% | 40,387 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $90,000 | -41.9% | 40,387 | -35.0% | 0.00% | 0.0% |
| Q2 2022 | $155,000 | +19.2% | 62,163 | +133.4% | 0.00% | 0.0% |
| Q1 2022 | $130,000 | -32.6% | 26,633 | +101.5% | 0.00% | -50.0% |
| Q3 2021 | $193,000 | -36.5% | 13,216 | -49.4% | 0.00% | -33.3% |
| Q2 2021 | $304,000 | +106.8% | 26,134 | +123.0% | 0.00% | +50.0% |
| Q4 2020 | $147,000 | -72.4% | 11,718 | -46.1% | 0.00% | -77.8% |
| Q2 2020 | $532,000 | – | 21,723 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |